β-amyloid-mediated inhibition of NMDA receptor-dependent long-term potentiation induction involves activation of microglia and stimulation of inducible nitric oxide synthase and superoxide

Journal of Neuroscience

Volumn 24, Issue 27, 2004, Pages 6049-6056

  Wang, Qinwen ^a   Rowan, Michael J ^a   Anwyl, Roger ^a  

^a TRINITY COLLEGE DUBLIN   (Ireland)

Author keywords

Amyloid protein; Caspases; Dentate gyrus; Inducible nitric oxide; LTP; Microglia; Superoxide

Indexed keywords

AMINOGUANIDINE; AMYLOID BETA PROTEIN; CATALASE; INDUCIBLE NITRIC OXIDE SYNTHASE; MINOCYCLINE; N [3 (AMINOMETHYL)BENZYL]ACETAMIDINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NITRIC OXIDE; PEROXYNITRITE; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE INHIBITOR; SCAVENGER; SUPEROXIDE; SUPEROXIDE DISMUTASE; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ANIMAL TISSUE; ARTICLE; BRAIN SLICE; CELL ACTIVATION; CONTROLLED STUDY; DENTATE GYRUS; ELECTROPHYSIOLOGY; IN VITRO STUDY; INFLAMMATION; KNOCKOUT MOUSE; LONG TERM DEPRESSION; LONG TERM POTENTIATION; MICROGLIA; NONHUMAN; PERFORANT NERVE TRACT; PRIORITY JOURNAL; PROTEIN INDUCTION; RAT;

AMYLOID BETA-PROTEIN; ANIMALS; ENZYME INHIBITORS; HIPPOCAMPUS; LONG-TERM DEPRESSION (PHYSIOLOGY); LONG-TERM POTENTIATION; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICROGLIA; MINOCYCLINE; NADPH OXIDASE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; OXIDANTS; PATCH-CLAMP TECHNIQUES; PERFORANT PATHWAY; PERFUSION; RATS; REACTIVE OXYGEN SPECIES; RECEPTORS, N-METHYL-D-ASPARTATE; SUPEROXIDES;

EID: 3042798841     PISSN: 02706474     EISSN: None     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.0233-04.2004     Document Type: Article

References (55)

1. Akama KT, Van Eldik LJV (2000) β-Amyloid stimulation of inducible nitric oxide synthase in astrocytes is IL-1β- and TNF-α-dependent. J Biol Chem 275:7918-7924.
2. Akama KT, Albanese C, Pestell RG, Van Eldik LJ (1998) Amyloid β-peptide stimulates nitric oxide production in astrocytes through an NF-κB-dependent mechanism. Proc Natl Acad Sci USA 95:5795-5800.
3. Akiyama H, Barger S, Barnum S, Bradt B, Bauer J, Cole GM, Cooper NR, Eikelenboom P, Emmerling M, Fiebich BL, Finch CE, Frautschy S, Griffin WS, Hampel H, Hull M, Landreth G, Lue L, Mrak R, MacKenzie IR, McGeer PL, et al. (2000) Inflammation and Alzheimer's disease. Neurobiol Aging 21:383-421.
4. Bamberger ME, Harris ME, McDonald DR, Husemann J, Landreth GE (2003) A cell surface receptor complex for fibrillar β-amyloid mediates microglial activation. J Neurosci 23:2665-2674.
5. Bianca VD, Dusi S, Bianchini E, Dal Pra I, Rossi F (1999) Beta-amyloid activates the O-2 forming NADPH oxidase in microglia, monocytes, and neutrophils. A possible inflammatory mechanism of neuronal damage in Alzheimer's disease. J Biol Chem 274:15493-15499.
6. Cavus I, Teyler T (1996) Two forms of long-term potentiation in area CA1 activate different signal transduction cascades. J Neurophysiol 76:3038-3047.
7. Chen Q, Kagan BL, Hirajura Y, Xie C (2000) Impairments of hippocampal long-term potentiation by Alzheimer β-peptide. J Neurosci Res 60:65-72.
8. Cobb MH (1999) MAP kinase pathways. Prog Biophys Mol Biol 71:479-500.
9. Combs CK, Johnson DE, Karlo JC, Cannady SB, Landreth GE (2000) Inflammatory mechanisms in Alzheimer's disease: inhibition of β-amyloid-stimulated proinflammatory responses and neurotoxicity by PPAR-γagonist. J Neurosci 20:558-567.
10. Cotman CW, Su JH (1996) Mechanisms of neuronal death in Alzheimer's disease. Brain Pathol 4:493-506.
11. Cullen WK, Suh Y-H, Anwyl R, Rowan MJ (1997) Block of LTP in rat hippocampus in vivo by β-amyloid precursor protein fragments. NeuroReport 8:3213-3217.
12. Da Silva J, Pierrat B, Mary JL, LessIauer W (1997) Blockade of p38 mitogen-activated protein kinase pathway inhibits inducible nitric-oxide synthase expression in mouse astrocytes. J Biol Chem 272:28373-28380.
13. Du Y, Ma Z, Lin S, Dodel RC, Gao F, Bales KR, Triarhou LC, Chernet E, Perry KW, Nelson DL, Luecke S, Phebus LA, Bymaster FP, Paul SM (2001) Minocycline prevents nigrostriatal dopaminergic neurodegeneration in the MPTP model of Parkinson's disease. Proc Natl Acad Sci USA 98: 14669-14674.
14. Eikelenboom P, Zahn SS, van Gool WA, Allsop D (1994) Inflammatory mechanisms in Alzheimer's disease. Trends Pharmacol Sci 15:447-450.
15. El Khoury J, Hickman SE, Thomas CA, Cao L, Silverstein SC, Loike JD (1996) Scavenger receptor-mediated adhesion of microglia to beta-amyloid fibrils. Nature 382:716-719.
16. Garvey EP, Oplinger JA, Furfine ES, Kiff RJ, Laszlo F, Whittle BJ, Knowles RG (1997) 1400W is a slow, tight-binding, and highly selective inhibitor of inducible nitric-oxide synthase in vitro and in vivo. J Biol Chem 272: 4959-4963.
17. Griffin WS, Sheng JC, Royston MC, Gentleman SM, McKenzie JE, Graham DI, Roberts GW, Mrak RE (1998) Glia1-neuronal interactions in Alzheimer's disease: the potential role of a cytokine cycle in disease progression. Brain Pathol 8:65-72.
18. Grover L (1998) Evidence for postsynaptic induction and expression of NMDA receptor independent LTP. J Neurophysiol 79:1167-1182.
19. Grover L, Teyler TJ (1990) Two components of long-term potentiation induced by different patterns of afferent activation. Nature 347:477-479.
20. Hensley K, Floyd RA, Zheng NY, Nael R, Robinson KA, Nguyen X, Pye QN, Stewart CA, Geddes J, Markesbery WR, Patel E, Johnson GV, Bing G (1999) p38 kinase is activated in the Alzheimer's disease brain. J Neurochem 72:2053-2058.
21. Hering H, Sheng M (2001) Dendritic spines: structure, dynamics, and regulation. Nat Rev Neurosci 2:880-888.
22. Itoh A, Akaike T, Sokabe M, Nitta A, Nabeshima T (1999) Impairment of long-term potentiation in hippocampal slices of β-amyloid-infused rats. Eur J Pharmacol 3:167-175.
23. Kamsler A, Segal M (2003) Paradoxical actions of hydrogen peroxide on long-term potentiation in transgenic superoxide dismutase-1 mice. J Neurosci 23:10359-10367.
24. Klann E, Robertson ED, Knapp LT, Sweatt JD (1998) A role for superoxide in protein kinase C activation and induction of long-term potentiation. J Biol Chem 273:4516-4522.
25. Lambert MP, Barlow AK, Chromy BA, Edwards C, Freed R, Liosatos M, Morgan TE, Rozovsky I, Trommer B, Viola KL, Wals P, Zhang C, Finch CE, Krafft GA, Klein WL (1998) Diffusible nonfibrillar ligands derived from Aβ1-42 are potent central nervous system neurotoxins. Proc Natl Acad Sci USA 95:6448-6453.
26. Laszlo F, Evans SM, Whittle BJ (1995) Aminoguanidine inhibits both constitutive and inducible nitric oxide synthase isoforms in rat intestinal microvasculature in vivo. Eur J Pharmacol 272:169-175.
27. Li R, Yang L, Lindholm K, Konishi Y, Yue X, Hampel H, Zhang D, Shen Y (2004) Tumor necrosis factor death receptor signaling cascade is required for amyloid-β protein-induced neuron death. J Neurosci 24:1760-1771.
28. Lin KT, Xue JY, Lin MC, Spokas EG, Sun FF, Wong PY (1998) Peroxynitrite induces apoptosis of HL-60 cells by activation of a caspase-3 family protease. Am J Physiol 274:C855-C860.
29. Lipton SA, Choi YB, Pan ZH, Lei SZ, Chen HS, Sucher NJ, Loscalzo J, Singel DJ, Stamler JS (1993) A redox-based mechanism for the neuroprotective and neurodestructive effects of nitric oxide and related nitroso-compounds. Nature 364:626-632.
30. Lisman J, Schulman H, Cline H (2002) The molecular basts of CaMKII function in synaptic and behavioural memory. Nat Rev Neurosci 3:175-190.
31. MacKenzie IR, Munoz DG (1998) Nonsteroidal anti-inflammatory use and Alzheimer-type pathology in aging. Neurology 50:986-990.
32. Martin SJ, Morris RG (2002) New life in an old idea: the synaptic plasticity and memory hypothesis revisited. Hippocampus 12:609-636.
33. McDonald DR, Brunden KR, Landreth GE (1997) Amyloid fibrils activate tyrosine kinase-dependent signaling and superoxide production in microglia. J Neurosci 17:2284-2288.
34. McGeer EG, McGeer PL (2003) Inflammatory processes in Alzheimer's disease. Prog Neuropsychopharmacol Biol Psychiatry 27:741-749.
35. McGeer PL, McGeer EG (1995) The inflammatory response system of the brain: implications for therapy of Alzheimer and other neurodegenerative diseases. Brain Res Rev 21:195-218.
36. Minghetti L, Levi G (1998) Microglia as effector cells in brain damage and repair: focus on prostanoids and nitric oxide. Prog Neurobiol 54:99-125.
37. Qin L, Liu Y, Cooper C, Liu B, Wilson B, Hong J-S (2002) Microglia enhance β-amyloid peptide-induced toxicity in cortical and mesencephalic neurons by producing reactive oxygen species. J Neurochem 83:973-983.
38. Raymond CR, Ireland DR, Abraham WC (2003) NMDA receptor regulation by amyloid-β does not account for its inhibition of LTP in rat hippocampus. Brain Res 968:263-272.
39. Sanchez Mejia RO, Ona VO, Li M, Friedlander RM (2001) Minocycline reduces traumatic brain injury-mediated caspase-1 activation, tissue damage, and neurological dysfunction. Neurosurgery 48:1393-1401.
40. Selkoe DJ (2002) Alzheimer's disease is a synaptic failure. Science 298:789-791.
41. Small DH, Mok SS, Bornstein JC (2001) Alzheimer's disease and Aβ toxicity: from top to bottom. Nat Rev Neurosci 8:595-598.
42. Smith MA, Richey-Harris PL, Sayre LM, Beckman JS, Perry G (1997) Wide-spread peroxynitrite-mediated damage in Alzheimer's disease. J Neurosci 17:2653-2657.
43. Stephan A, Laroche S, Davis S (2001) Generation of aggregated β-amyloid in the rat hippocampus impairs synaptic transmission and plasticity and causes memory deficits. J Neurosci 21:5703-5714.
44. Tan J, Town T, Paris D, Mori T, Suo Z, Crawford F, Mattson MP, Flavell RA, Mullan M (1999) Microglial activation resulting from CD40-CD40L interaction after β-amyloid stimulation. Science 286:2352-2355.
45. Tikka T, Fiebich B, Goldsteins G, Keinanen R, Koistinaho J (2001) Minocycline, a tetracycline derivative, is neuroprotective against excitotoxicity by inhibiting activation and proliferation of microglia. J Neurosci 21:2580-2588.
46. Toni N, Buchs PA, Nikonenko I, Bron CR, Muller D (1999) (1999) LTP promotes formation of multiple spine synapses between a single axon terminal and a dendrite. Nature 402:421-425.
47. Vitolo OV, Sant'Angelo A, Costanzo V, Battaglia F, Arancio O, Shelanski M (2002) Amyloid β-peptide inhibition of the PKA/CREB pathway and long-term potentiation: reversibility by drugs that enhance cAMP signaling. Proc Natl Acad Sci USA 99:13217-13221.
48. Wallace MN, Geddes JG, Farquar DA, Masson MR (1997) Nitric oxide synthase in reactive astrocytes adjacent to β-amyloid. Exp Neurol 144:266-272.
49. Walsh DM, Klyubuin I, Fadeeva J, Cullen WK, Anwyl R, Wolfe MS, Rowan MJ, Selkoe DJ (2002) Naturally secreted oligomers of the Alzheimer amyloid β-protein potently inhibit long-term potentiation in vivo. Nature 416:535-539.
50. Wang H-W, Pasternak JF, Kuo H, Ristic H, Lambert MP, Chromy B, Violoa KL, Klein WL, Stine WB, Krafft GA, Trommer BL (2002) Soluble oligomers of β amyloid (1-42) inhibit long-term depression but not long-term depression in the dentate gyrus. Brain Res 924:133-140.
51. Wang Q, Walsh DM, Rowan MJ, Selkoe DJ, Anwyl R (2004) Block of LTP by naturally secreted and synthetic amyloid β-peptide in hippocampal slices is mediated via activation of the kinases JNK, Cdk5, and p38 MAPK as well as mGluR5. J Neurosci 24:3370-3378.
52. Wu J, Rowan MJ, Anwyl R (2004) An NMDAR-independent LTP mediated by group II metabotropic glutamate receptors and p42/44 MAP kinase in the dentate gyrus in vitro. Neuropharmacology 46:311-331.
53. Yah SD, Chen X, Fu J, Zhu H, Roher A, Slattery T, Morser J, Nawroth P, Stern D, Schmidt AM (1996) RAGE and amyloid-β peptide neurotoxicity in Alzheimer's disease. J Biol Chem 274:15493-15499.
54. Yrjanheikki J, Keinnanen R, Pellikka M, Hokfelt T, Koistinaho J (1998) Tetracydines inhibit microglial activation and are neuroprotective in global brain ischemia. Proc Natl Acad Sci USA 95:15769-15774.
55. Zhu S, Stavrovskaya IG, Drozda M, Kim BY, Ona V, Li M, Sarang S, Liu AS, Hartley DM, Wu du C, Gullans S, Ferrante RJ, Przedborski S, Kristal BS, Friedlander RM (2002) Minocycline inhibits cytochrome c release and delays progression of amyotrophic lateral sclerosis in mice. Nature 417: 74-78.